相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study
Mary E. Rinella et al.
JOURNAL OF HEPATOLOGY (2022)
Randomised clinical trial: Semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging
Anne Flint et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Hepatic stellate cell senescence in liver fibrosis: Characteristics, mechanisms and perspectives
Mengfan Zhang et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2021)
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
V. Ratziu et al.
NATURE MEDICINE (2021)
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Sven M. Francque et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis
Zhong-Yi Wang et al.
SCIENTIFIC REPORTS (2021)
Metabolic Reprogramming of Liver Fibrosis
M. Eugenia Delgado et al.
CELLS (2021)
Cellular Mechanisms of Liver Fibrosis
Pragyan Acharya et al.
FRONTIERS IN PHARMACOLOGY (2021)
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam et al.
CELLS (2021)
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Ruchi Kumari et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Novel Immune Subsets and Related Cytokines: Emerging Players in the Progression of Liver Fibrosis
Minjie Wan et al.
FRONTIERS IN MEDICINE (2021)
Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model
Taihua Yang et al.
JOURNAL OF HEPATOLOGY (2021)
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
Martina Rossi et al.
CELLS (2021)
Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy
Zui Tan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
A Cross-Platform Metabolomics Comparison Identifies Serum Metabolite Signatures of Liver Fibrosis Progression in Chronic Hepatitis C Patients
Meera Shanmuganathan et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Xiaolin Wang et al.
GUT (2021)
MicroRNA-223 restricts liver fibrosis by inhibiting the TAZ-IHH-GLI2 and PDGF signaling pathways via the crosstalk of multiple liver cell types
Bin Gao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Molecular and cellular mechanisms of liver fibrosis and its regression
Tatiana Kisseleva et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
AT-MSCs Antifibrotic Activity is Improved by Eugenol through Modulation of TGF-β/Smad Signaling Pathway in Rats
Moustafa Fathy et al.
MOLECULES (2020)
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
Sudeep Tanwar et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
hUCMSC-extracellular vesicles downregulated hepatic stellate cell activation and reduced liver injury in S. japonicum-infected mice
Liyang Dong et al.
STEM CELL RESEARCH & THERAPY (2020)
The ECM path of senescence in aging: components and modifiers
Naama Levi et al.
FEBS JOURNAL (2020)
TSG-6 Inhibits Oxidative Stress and Induces M2 Polarization of Hepatic Macrophages in Mice With Alcoholic Hepatitis via Suppression of STAT3 Activation
Yue-Meng Wan et al.
FRONTIERS IN PHARMACOLOGY (2020)
Ultrasound-targeted microbubble destruction optimized HGF-overexpressing bone marrow stem cells to repair fibrotic liver in rats
Ting Sun et al.
STEM CELL RESEARCH & THERAPY (2020)
A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis
Tae Gyu Oh et al.
CELL METABOLISM (2020)
Gut Microbiota and Liver Fibrosis: One Potential Biomarker for Predicting Liver Fibrosis
Zhiming Li et al.
BIOMED RESEARCH INTERNATIONAL (2020)
The nonalcoholic steatohepatitis (NASH) drug development graveyard: established hurdles and planning for future success
Joost P. H. Drenth et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Patricia Rada et al.
CELL DEATH & DISEASE (2020)
TGF-β Pathway in Salivary Gland Fibrosis
Xianglan Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment
Claire E. McQuitty et al.
FRONTIERS IN IMMUNOLOGY (2020)
Lysophosphatidic Acid Receptors: Biochemical and Clinical Implications in Different Diseases
Hongjiao Xiang et al.
JOURNAL OF CANCER (2020)
Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities
Suzy Varderidou-Minasian et al.
THERANOSTICS (2020)
Epidemiology of non-alcoholic and alcoholic fatty liver diseases
Souveek Mitra et al.
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Burden of liver diseases in the world
Sumeet K. Asrani et al.
JOURNAL OF HEPATOLOGY (2019)
Fibrosis and alcohol-related liver disease
Carolin Lackner et al.
JOURNAL OF HEPATOLOGY (2019)
Senescent cells: Living or dying is a matter of NK cells
Fabrizio Antonangeli et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease
Cyrielle Caussy et al.
NATURE COMMUNICATIONS (2019)
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
Oliver Krenkel et al.
CELLS (2019)
The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease
Julia Driscoll et al.
JOURNAL OF GASTROENTEROLOGY (2019)
REGENERATE: Design of a pivotal, randomised, phase 3 study evaluating the safety and efficacy of obeticholic acid in patients with fibrosis due to nonalcoholic steatohepatitis
Vlad Ratziu et al.
CONTEMPORARY CLINICAL TRIALS (2019)
Interleukin-9 blockage reduces early hepatic granuloma formation and fibrosis during Schistosoma japonicum infection in mice
Tingzheng Zhan et al.
IMMUNOLOGY (2019)
Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
Emilie Garnaes et al.
PLOS ONE (2019)
Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis
Liting Zhang et al.
MEDICAL SCIENCE MONITOR (2019)
Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse
Sihyung Wang et al.
BIOMATERIALS (2019)
The JAK inhibitor tofacitinib ameliorates immune-mediated liver injury in mice
Han Wang et al.
MOLECULAR MEDICINE REPORTS (2019)
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
P. Ramachandran et al.
NATURE (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Non-alcoholic fatty liver disease - A global public health perspective
Zobair M. Younossi
JOURNAL OF HEPATOLOGY (2019)
Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) as Serological Fibrosis Marker
Ozlem Akdogan et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Synergistic effects of simvastatin and bone marrow-derived mesenchymal stem cells on hepatic fibrosis
Yoon Ok Jang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
A COL1A1 Promoter-Controlled Expression of TGF- Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses
Shouhua Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation
Katrin Bottcher et al.
HEPATOLOGY (2018)
Extracellular vesicles derived from human embryonic stem cell-MSCs ameliorate cirrhosis in thioacetamide-induced chronic liver injury
Soura Mardpour et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Extracellular matrix as a driver of progressive fibrosis
Jeremy Herrera et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Clinical states of cirrhosis and competing risks
Gennaro D'Amico et al.
JOURNAL OF HEPATOLOGY (2018)
Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening
Patrick Marcellin et al.
LIVER INTERNATIONAL (2018)
Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies
Esteban Juan Fiore et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
Pushpa Hegde et al.
NATURE COMMUNICATIONS (2018)
Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension
Kwang Yong Shim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
Niaz Mahmood et al.
FRONTIERS IN ONCOLOGY (2018)
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
Scott M. Palmer et al.
CHEST (2018)
Conditioned Medium from Human Amnion-Derived Mesenchymal Stem Cells Regulates Activation of Primary Hepatic Stellate Cells
Qingjie Fu et al.
STEM CELLS INTERNATIONAL (2018)
Unraveling SSc Pathophysiology; The Myofibroblast
Arjan van Caam et al.
FRONTIERS IN IMMUNOLOGY (2018)
Type 3 cytokines IL-17A and IL-22 drive TGF-β-dependent liver fibrosis
Thomas Fabre et al.
SCIENCE IMMUNOLOGY (2018)
Increased Expression of Resistin in MicroRNA-155-Deficient White Adipose Tissues May Be a Possible Driver of Metabolically Healthy Obesity Transition to Classical Obesity
Candice Johnson et al.
FRONTIERS IN PHYSIOLOGY (2018)
Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression
Krishna Sumanth Nallagangula et al.
FUTURE SCIENCE OA (2018)
Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice
Su Yeon An et al.
GASTROENTEROLOGY (2017)
Identification of senescent cell surface targetable protein DPP4
Kyoung Mi Kim et al.
GENES & DEVELOPMENT (2017)
TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
Evangelia Pardali et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Cytokines Genotype-Phenotype Correlation in Nonalcoholic Steatohepatitis
Ioana Corina Bocsan et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Plasma Level of Soluble Urokinase-type Plasminogen Activator Receptor Predicts the Severity of Acute Alcohol Pancreatitis
Anssi Nikkola et al.
PANCREAS (2017)
Platelets in liver disease, cancer and regeneration
Tomohiro Kurokawa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
The roles of microRNA families in hepatic fibrosis
Xue-Ping Jiang et al.
CELL AND BIOSCIENCE (2017)
Interferon-γ Treatment of Human Laryngotracheal Stenosis-Derived Fibroblasts
Kevin Motz et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2017)
Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance
Akiko Yamada et al.
Frontiers in Immunology (2017)
Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
Anushruti Sarvaria et al.
FRONTIERS IN IMMUNOLOGY (2017)
Epigenetics and Liver Fibrosis
Eva Moran-Salvador et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
The New-Generation Pan-Peroxisome Proliferator-Activated Receptor Agonist IVA337 Protects the Liver From Metabolic Disorders and Fibrosis
Guillaume Wettstein et al.
HEPATOLOGY COMMUNICATIONS (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Common pathway signature in lung and liver fibrosis
Eugene Makarev et al.
CELL CYCLE (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Thomas A. Wynn et al.
IMMUNITY (2016)
Fine-tuning the expression of microRNA-155 controls acetaminophen-induced liver inflammation
Kai Yuan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
TGF-/SMAD Pathway and Its Regulation in Hepatic Fibrosis
Fengyun Xu et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2016)
Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively
Biao Huang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Rapamycin ameliorates CCl4-induced liver fibrosis in mice through reciprocal regulation of the Th17/Treg cell balance
Lei Gu et al.
MOLECULAR MEDICINE REPORTS (2016)
MicroRNA-15a Inhibits Proliferation and Induces Apoptosis in CNE1 Nasopharyngeal Carcinoma Cells
Kang Zhu et al.
ONCOLOGY RESEARCH (2016)
Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets
Chong-Yang Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells
Nancy Magee et al.
BIOMED RESEARCH INTERNATIONAL (2016)
Non-invasive Markers of Liver Fibrosis: Adjuncts or Alternatives to Liver Biopsy?
Jun L. Chin et al.
FRONTIERS IN PHARMACOLOGY (2016)
Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
Mio Kitano et al.
JOURNAL OF CLINICAL MEDICINE (2016)
The Immune Landscape in Nonalcoholic Steatohepatitis
Sowmya Narayanan et al.
IMMUNE NETWORK (2016)
TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver
Susanne Nicole Weber et al.
PLOS ONE (2016)
Roles of hepatic stellate cells in liver inflammation: a new perspective
Tomoko Fujita et al.
INFLAMMATION AND REGENERATION (2016)
Mo1351 Systemic Levels of Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Predict the Severity of Acute Alcohol Pancreatitis
Anssi Nikkola et al.
GASTROENTEROLOGY (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
Fibrates and cholestasis
Nisanne S. Ghonem et al.
HEPATOLOGY (2015)
Hepatic fibrosis: Concept to treatment
Christian Trautwein et al.
JOURNAL OF HEPATOLOGY (2015)
Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway
Li-Ting Zhang et al.
MOLECULAR MEDICINE REPORTS (2015)
The miR-15 Family Enhances the Radiosensitivity of Breast Cancer Cells by Targeting G2 Checkpoints
Zijie Mei et al.
RADIATION RESEARCH (2015)
MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1
Gangli Yan et al.
MEDICAL SCIENCE MONITOR (2015)
Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis
Yang Jiao et al.
ACTA PHARMACOLOGICA SINICA (2015)
Acute and chronic immune biomarker changes during interferon/ribavirin treatment in HIV/HCV co-infected patients
M. K. Jain et al.
JOURNAL OF VIRAL HEPATITIS (2015)
Activation of Mir-29a in Activated Hepatic Stellate Cells Modulates Its Profibrogenic Phenotype through Inhibition of Histone Deacetylases 4
Ying-Hsien Huang et al.
PLOS ONE (2015)
Building better monoclonal antibody-based therapeutics
George J. Weiner
NATURE REVIEWS CANCER (2015)
Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection
Melanie A. Gasper et al.
AIDS (2014)
MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase
Yifei Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
Yoon Ok Jang et al.
BMC GASTROENTEROLOGY (2014)
Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis
Ali A. Mokdad et al.
BMC MEDICINE (2014)
IL-30 (IL27p28) Attenuates Liver Fibrosis Through Inducing NKG2D-Rae1 Interaction Between NKT and Activated Hepatic Stellate Cells in Mice
Abhisek Mitra et al.
HEPATOLOGY (2014)
Epigenetic Regulation of Connective Tissue Growth Factor by MicroRNA-214 Delivery in Exosomes From Mouse or Human Hepatic Stellate Cells
Li Chen et al.
HEPATOLOGY (2014)
Human Bone Marrow Mesenchymal Stem Cell-Derived Hepatocytes Improve the Mouse Liver after Acute Acetaminophen Intoxication by Preventing Progress of Injury
Peggy Stock et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Biomarkers of liver cell death
Akiko Eguchi et al.
JOURNAL OF HEPATOLOGY (2014)
Image analysis of liver biopsy samples measures fibrosis and predicts clinical outcome
Yi Huang et al.
JOURNAL OF HEPATOLOGY (2014)
Remodelling the extracellular matrix in development and disease
Caroline Bonnans et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
Forouzan Faghihzadeh et al.
NUTRITION RESEARCH (2014)
Diverse roles of miR-29 in cancer (Review)
Hesong Jiang et al.
ONCOLOGY REPORTS (2014)
IL-12 Directs Further Maturation of Ex Vivo Differentiated NK Cells with Improved Therapeutic Potential
Dorit Lehmann et al.
PLOS ONE (2014)
Systems Genetics of Liver Fibrosis: Identification of Fibrogenic and Expression Quantitative Trait Loci in the BXD Murine Reference Population
Rabea A. Hall et al.
PLOS ONE (2014)
Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor
Dwi U. Kemaladewi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Mucosal-associated invariant T-cells: new players in anti-bacterial immunity
James E. Ussher et al.
FRONTIERS IN IMMUNOLOGY (2014)
Evolving therapies for liver fibrosis
Detlef Schuppan et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
IL-17A Plays a Critical Role in the Pathogenesis of Liver Fibrosis through Hepatic Stellate Cell Activation
Zhongming Tan et al.
JOURNAL OF IMMUNOLOGY (2013)
Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality
H. W. Zimmermann et al.
JOURNAL OF INTERNAL MEDICINE (2013)
IL-22 Promotes Fibroblast-Mediated Wound Repair in the Skin
Heather M. McGee et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice
Michio Hara et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Interleukin-1β upregulates matrix metalloproteinase-13 gene expression via c-Jun N-terminal kinase and p38 MAPK pathways in rat hepatic stellate cells
Ning Tang et al.
MOLECULAR MEDICINE REPORTS (2013)
Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Liver Fibrosis
Tingfen Li et al.
STEM CELLS AND DEVELOPMENT (2013)
Role of Integrin αvβ6 in the Pathogenesis of Ischemia-Related Biliary Fibrosis After Liver Transplantation
Geng Chen et al.
TRANSPLANTATION (2013)
Acyclic Retinoid Targets Platelet-Derived Growth Factor Signaling in the Prevention of Hepatic Fibrosis and Hepatocellular Carcinoma Development
Hikari Okada et al.
CANCER RESEARCH (2012)
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
Fanli Meng et al.
GASTROENTEROLOGY (2012)
Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice
Tsuyoshi Ishikawa et al.
HEPATOLOGY (2012)
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Xiaoni Kong et al.
HEPATOLOGY (2012)
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy
Cheng-Yuan Peng et al.
JOURNAL OF HEPATOLOGY (2012)
Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
Geoffrey Porez et al.
JOURNAL OF LIPID RESEARCH (2012)
Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis
H. Q. Sun et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation
Darwin J. Prockop et al.
MOLECULAR THERAPY (2012)
Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis
Henning W. Zimmermann et al.
LIVER INTERNATIONAL (2012)
Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'
Aron M. Levin et al.
NATURE (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Mechanisms of hepatic fibrogenesis
Ursula E. Lee et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells
Mathilde Dusseaux et al.
BLOOD (2011)
Non-Invasive markers for hepatic fibrosis
Ancha Baranova et al.
BMC GASTROENTEROLOGY (2011)
Tumor-Secreted Lysophostatidic Acid Accelerates Hepatocellular Carcinoma Progression by Promoting Differentiation of Peritumoral Fibroblasts in Myofibroblasts
Antonio Mazzocca et al.
HEPATOLOGY (2011)
Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture
Sarmistha Bandyopadhyay et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction
Monika Kwiecinski et al.
PLOS ONE (2011)
Extracellular Matrix Degradation and Remodeling in Development and Disease
Pengfei Lu et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Suppression of type I collagen production by microRNA-29b in cultured human stellate cells
Tomohiro Ogawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model
J. S. Swaney et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression
Vahideh Rabani et al.
CELL BIOLOGY INTERNATIONAL (2010)
Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats
H-Y Yue et al.
GUT (2010)
Interleukin-22 Treatment Ameliorates Alcoholic Liver Injury in a Murine Model of Chronic-Binge Ethanol Feeding: Role off Signal Transducer and Activator of Transcription 3
Sung Hwan Ki et al.
HEPATOLOGY (2010)
Long-Term Entecavir Therapy Results in the Reversal of Fibrosis/Cirrhosis and Continued Histological Improvement in Patients with Chronic Hepatitis B
Ting-Tsung Chang et al.
HEPATOLOGY (2010)
Amelioration of high fat diet induced liver lipogenesis and hepatic steatosis by interleukin-22
Ling Yang et al.
JOURNAL OF HEPATOLOGY (2010)
Quantitative and Qualitative Alterations of Heparan Sulfate in Fibrogenic Liver Diseases and Hepatocellular Cancer
Peter Tatrai et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2010)
Chemokines as inflammatory mediators of fibrosis in liver fibrosis
H E Wasmuth
Journal of Translational Medicine (2010)
The discovery of Hepatocyte Growth Factor (HGF) and its significance for cell biology, life sciences and clinical medicine
Toshikazu Nakamura et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2010)
The immunology of fibrosis: innate and adaptive responses
Georg Wick et al.
TRENDS IN IMMUNOLOGY (2010)
Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C
Jordi Colmenero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
CXCR3, Inflammation, and Autoimmune Diseases
Stephanie Lacotte et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies
Yury Popov et al.
HEPATOLOGY (2009)
Susceptibility to Liver Fibrosis in Mice Expressing a Connective Tissue Growth Factor Transgene in Hepatocytes
ZhenYue Tong et al.
HEPATOLOGY (2009)
Reversibility of liver fibrosis
Prakash Ramachandran et al.
ANNALS OF HEPATOLOGY (2009)
HGF as a renotrophic and anti-fibrotic regulator in chronic renal disease
Shinya Mizuno et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Inhibition of integrin αvβ6 on cholangiocytes blocks transforming growth factor-β activation and retards biliary fibrosis progression
Eleonora Patsenker et al.
GASTROENTEROLOGY (2008)
Preassociation of IL-15 with IL-15Rα-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action
Sigrid Dubois et al.
JOURNAL OF IMMUNOLOGY (2008)
PDGF-C is a proinflammatory cytokine that mediates renal interstitial fibrosis
Frank Eitner et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Grading and staging systems for inflammation and fibrosis in chronic liver diseases
Zachary D. Goodman
JOURNAL OF HEPATOLOGY (2007)
Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression
Swati Biswas et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
Christopher P. Denton et al.
ARTHRITIS AND RHEUMATISM (2007)
Hepatocyte growth factor: a regenerative drug for acute hepatitis and liver cirrhosis
Shinya Mizuno et al.
REGENERATIVE MEDICINE (2007)
Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice
Martin Roderfeld et al.
FASEB JOURNAL (2006)
Tumor necrosis factor (TNF) α increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2
AL Theiss et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts
T Nakamura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis
WH Kim et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids
F Geissmann et al.
PLOS BIOLOGY (2005)
Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma
JS Campbell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis
S Mizuno et al.
FASEB JOURNAL (2005)
CXC chemokine ligand 16 promotes integrin-mediated adhesion of liver-infiltrating lymphocytes to cholangiocytes and hepatocytes within the inflamed human liver
M Heydtmann et al.
JOURNAL OF IMMUNOLOGY (2005)
Interleukin-15 enhances cytotoxicity, receptor expression, and expansion of neonatal natural killer cells in long-term culture
SS Choi et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Suppressions of chronic glomerular injuries and TGF-beta(1) production by HGF in attenuation of murine diabetic nephropathy
S Mizuno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2004)
Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro
A Saito et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2003)
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells
K Le Blanc et al.
EXPERIMENTAL HEMATOLOGY (2003)
Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy
A Pontén et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
The emerging role of lysophosphatidic acid in cancer
GB Mills et al.
NATURE REVIEWS CANCER (2003)
TSG-6: a multifunctional protein associated with inflammation
CM Milner et al.
JOURNAL OF CELL SCIENCE (2003)
Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis
AW Rachfal et al.
HEPATOLOGY RESEARCH (2003)
Histological outcome during long-term lamivudine therapy
JL Dienstag et al.
GASTROENTEROLOGY (2003)
Cartilage-specific constitutive expression of TSG-6 protein (product of tumor necrosis factor α-stimulated gene 6) provides a chondroprotective, but not antiinflammatory, effect in antigen-induced arthritis
TT Glant et al.
ARTHRITIS AND RHEUMATISM (2002)
A novel allelic variant of the human TSG-6 gene encoding an amino acid difference in the CUB module -: Chromosomal localization, frequency analysis, modeling, and expression
HA Nentwich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase-dependent pathway
S Hashimoto et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors
R Issa et al.
GUT (2001)
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct
P Hammel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages
T Shimaoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
PDGF-C is a new protease-activated ligand for the PDGF α-receptor
XR Li et al.
NATURE CELL BIOLOGY (2000)
Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
K Kovalovich et al.
HEPATOLOGY (2000)
分享论文
